Double maintains 6 strategies that include GH - Guardant Health, Inc.
Current Value
$50.741 Year Return
Current Value
$50.741 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| QNTM | 0.03% | $51.29M | +99.37% | 0.00% |
| PGR | -0.04% | $146.19B | +17.73% | 1.98% |
| BTI | -0.09% | $111.18B | +57.68% | 6.01% |
| MSIF | -0.12% | $773.71M | +36.92% | 7.56% |
| WRB | 0.15% | $26.23B | +34.84% | 0.48% |
| PRPO | -0.19% | $23.73M | +229.04% | 0.00% |
| FIZZ | 0.22% | $4.21B | -10.24% | 0.00% |
| LTM | 0.24% | $12.85B | -95.43% | 2.39% |
| UL | -0.26% | $150.82B | +8.55% | 3.19% |
| GO | 0.29% | $1.26B | -39.10% | 0.00% |
| NOC | 0.33% | $73.96B | +18.95% | 1.66% |
| AIFU | -0.34% | $17.40M | +87.81% | 0.00% |
| TSN | 0.38% | $19.08B | -3.94% | 3.65% |
| CI | -0.45% | $82.49B | -7.43% | 1.90% |
| LMT | 0.47% | $108.79B | +0.85% | 2.81% |
| HAIN | 0.48% | $145.31M | -77.16% | 0.00% |
| KVUE | 0.51% | $40.16B | +16.74% | 3.94% |
| ERIE | 0.55% | $16.36B | -3.05% | 1.53% |
| AZO | 0.56% | $62.37B | +29.38% | 0.00% |
| ODP | -0.56% | $558.63M | -52.43% | 0.00% |
Yahoo
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Yahoo
New integration brings Guardant Health's complete oncology testing portfolio into the VieCure Halo Intelligence platform, streamlining access to precision diagnostics at the point of care DENVER, CO / ACCESS Newswire / July 10, 2025 / VieCure Inc., ...
Yahoo
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
Yahoo
Guardant Health’s first quarter results were shaped by strong growth in both its oncology and screening businesses, with management crediting product upgrades and increasing test volumes as key drivers. Co-CEO Helmy Eltoukhy pointed to “some of the strongest growth we’ve seen in a number of years” for Guardant360, following recent enhancements to its liquid biopsy platform, while the Reveal test contributed additional volume gains. Management also highlighted operational improvements and reimbur
Yahoo
Guardant Health’s first quarter results were driven by strong growth in its core oncology business and continued momentum for its new Shield screening product. Management attributed the quarter’s performance to volume acceleration in Guardant360 and Reveal, supported by upgrades to its smart liquid biopsy platform and expanded reimbursement coverage. Co-CEO Helmy Eltoukhy emphasized the impact of workflow improvements, noting that Reveal achieved gross margin positivity for the first time, mainl
Yahoo
GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TWST | 49.88% | $2.30B | -26.70% | 0.00% |
| TEM | 47.93% | $10.32B | +58.93% | 0.00% |
| VCYT | 47.93% | $2.16B | +21.93% | 0.00% |
| ALTG | 47.18% | $282.46M | -3.62% | 2.73% |
| CYRX | 47.07% | $376.53M | +6.83% | 0.00% |
| NTRA | 45.89% | $22.31B | +47.42% | 0.00% |
| SDGR | 45.44% | $1.59B | +0.70% | 0.00% |
| EPAM | 45.04% | $10.07B | -6.04% | 0.00% |
| ACA | 45.01% | $4.48B | +7.70% | 0.22% |
| ALNT | 44.84% | $660.74M | +48.23% | 0.31% |
| QTWO | 44.72% | $5.77B | +41.29% | 0.00% |
| OC | 44.71% | $12.78B | -14.23% | 1.74% |
| RGEN | 44.68% | $7.53B | +6.21% | 0.00% |
| RAMP | 44.24% | $2.21B | +6.52% | 0.00% |
| BROS | 44.19% | $8.09B | +58.96% | 0.00% |
| KFY | 44.04% | $3.88B | +13.37% | 2.28% |
| HOOD | 44.01% | $87.10B | +347.82% | 0.00% |
| RDW | 43.50% | $2.23B | +110.07% | 0.00% |
| LFMD | 43.44% | $543.55M | +91.05% | 0.00% |
| BLFS | 43.34% | $1.09B | +8.35% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FTXG | -0.09% | $22.44M | 0.6% |
| IBTK | 0.19% | $445.94M | 0.07% |
| VGIT | -0.23% | $31.63B | 0.04% |
| CARY | 0.34% | $347.36M | 0.8% |
| PSQA | 0.46% | $36.49M | 0.2% |
| BSV | -0.49% | $37.89B | 0.03% |
| SHY | -0.59% | $23.54B | 0.15% |
| CGSM | 0.60% | $716.74M | 0.25% |
| SCHR | 0.61% | $10.79B | 0.03% |
| BSMR | -0.62% | $258.51M | 0.18% |
| SHYD | -0.63% | $331.91M | 0.35% |
| SMMU | -0.74% | $896.32M | 0.35% |
| TIPX | 0.89% | $1.73B | 0.15% |
| IBTL | 1.04% | $381.26M | 0.07% |
| TDTT | 1.05% | $2.63B | 0.18% |
| JPST | -1.06% | $31.93B | 0.18% |
| IBTM | 1.17% | $316.60M | 0.07% |
| BNDX | -1.20% | $67.46B | 0.07% |
| DFNM | 1.23% | $1.58B | 0.17% |
| IEI | -1.27% | $15.53B | 0.15% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 60.55% | $1.03B | 0.75% |
| GNOM | 53.22% | $46.47M | 0.5% |
| IWO | 53.04% | $11.77B | 0.24% |
| KOMP | 51.49% | $2.34B | 0.2% |
| VBK | 51.38% | $19.19B | 0.07% |
| RDTE | 51.01% | $139.04M | 0.97% |
| CWB | 50.76% | $3.91B | 0.4% |
| IWC | 50.70% | $840.86M | 0.6% |
| VXF | 50.66% | $22.53B | 0.05% |
| XSW | 50.61% | $509.81M | 0.35% |
| FNY | 50.60% | $389.03M | 0.7% |
| ISCG | 50.46% | $688.57M | 0.06% |
| PTH | 50.41% | $96.25M | 0.6% |
| KJAN | 50.17% | $279.50M | 0.79% |
| VTWO | 50.04% | $12.65B | 0.07% |
| ICVT | 50.01% | $2.67B | 0.2% |
| SMLF | 49.82% | $1.88B | 0.15% |
| IWM | 49.79% | $65.64B | 0.19% |
| WCLD | 49.43% | $377.26M | 0.45% |
| SCHA | 49.35% | $17.61B | 0.04% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -43.06% | $315.93M | 1.43% |
| VIXY | -39.01% | $184.73M | 0.85% |
| TAIL | -32.76% | $94.86M | 0.59% |
| IVOL | -19.05% | $342.69M | 1.02% |
| FXY | -15.27% | $802.69M | 0.4% |
| XONE | -12.22% | $628.85M | 0.03% |
| SHYM | -12.22% | $355.86M | 0.35% |
| BUXX | -11.63% | $312.40M | 0.25% |
| TPMN | -11.12% | $31.06M | 0.65% |
| ULST | -9.75% | $592.38M | 0.2% |
| CANE | -9.58% | $11.14M | 0.29% |
| BILS | -8.85% | $3.80B | 0.1356% |
| SPTS | -8.71% | $5.77B | 0.03% |
| STOT | -8.66% | $252.82M | 0.45% |
| GSST | -8.62% | $920.88M | 0.16% |
| CLIP | -8.38% | $1.55B | 0.07% |
| TBLL | -8.38% | $2.12B | 0.08% |
| USDU | -8.05% | $129.80M | 0.5% |
| KCCA | -7.70% | $108.37M | 0.87% |
| FMHI | -7.66% | $746.85M | 0.7% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -23.57% | $24.55B | +38.09% | 1.08% |
| KMB | -18.27% | $43.78B | -6.43% | 3.77% |
| MO | -17.93% | $98.62B | +24.36% | 7.00% |
| ED | -15.99% | $36.42B | +10.51% | 3.36% |
| AWK | -15.64% | $27.82B | +4.74% | 2.18% |
| CME | -14.66% | $99.17B | +44.04% | 1.75% |
| VZ | -14.49% | $177.21B | +1.77% | 8.05% |
| K | -13.28% | $27.64B | +40.17% | 2.86% |
| CL | -12.71% | $73.44B | -7.30% | 2.25% |
| CAG | -12.33% | $9.30B | -31.32% | 7.20% |
| PPC | -11.37% | $10.64B | +33.60% | 0.00% |
| MDLZ | -11.34% | $86.95B | +2.80% | 2.82% |
| GIS | -11.30% | $27.86B | -18.70% | 5.88% |
| VSA | -10.88% | $8.59M | -17.17% | 0.00% |
| TEF | -10.82% | $29.35B | +18.72% | 6.32% |
| KO | -10.54% | $300.31B | +10.57% | 2.87% |
| PEP | -10.26% | $186.58B | -17.00% | 4.07% |
| CPB | -10.13% | $9.09B | -32.74% | 5.09% |
| SO | -9.76% | $102.50B | +16.78% | 3.13% |
| T | -9.38% | $198.74B | +46.45% | 5.06% |
